Company overview
Teijin Limited is a diversified technology company offering pharmaceutical products, home healthcare equipment covered by insurance, and advanced high-performance materials including aramid fibers, carbon fibers, and composites. The company operates a global network of production and development capabilities, with Japan's leading market share in CPAP devices for home therapy. Teijin serves life sciences and pharmaceutical sectors through both direct medical equipment offerings and specialized materials for industrial applications.
Advanced Materials & Medical Equipment Supplier is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include pharmaceutical supplier, medical equipment, cpap devices, aramid fibers, carbon fiber composites, high-performance materials.
Structured facts
- Website
- https://www.teijin.com
- Markets served
- United States & Americas
- Keywords
- pharmaceutical supplier, medical equipment, cpap devices, aramid fibers, carbon fiber composites, high-performance materials
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Frequently asked questions
- What pharmaceutical and medical products does Teijin supply?
- Teijin develops business in pharmaceuticals and home healthcare equipment covered by insurance. The company holds Japan's No. 1 market share in CPAP devices for home therapy and offers a range of pharmaceutical products through its diversified portfolio.
- What advanced materials does Teijin offer for life sciences applications?
- Teijin manufactures high-performance aramid fibers (Twaron, Conex, Technora), carbon fibers, composites, films, sheets, and specialty polymers. These materials are used in protective clothing, medical devices, aerospace structures, and industrial applications requiring exceptional strength and chemical resistance.
- What is Teijin's geographic presence and manufacturing capability?
- Teijin operates a strong global network of production, development, and supply chain capabilities. The company has operations spanning multiple regions, including a dedicated subsidiary in the Netherlands (Teijin Aramid) and operations in the USA and other key markets.
- How does Teijin support R&D and innovation?
- Teijin invests in research and development with capabilities in digital transformation, IoT monitoring technology, machine learning, AI technology, and materials informatics to enhance innovation and product development across its portfolio.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
